[1]
“Sex differences in prescription patterns of secondary prevention pharmacotherapy in patients with acute myocardial infarction: a 20-year insight from the AMIS Plus registry”, Swiss Med Wkly, vol. 156, no. 9, p. 4681, Sep. 2026, doi: 10.57187/4681.